# Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation

> **NCT07648992** · PHASE4 · RECRUITING · sponsor: **Daihong Liu** · enrollment: 324 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Anti-Thymocyte Globulin
- **DRUG:** Anti-Thymocyte Globulin

## Key facts

- **NCT ID:** NCT07648992
- **Lead sponsor:** Daihong Liu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2029-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 324 (ESTIMATED)
- **Last updated:** 2026-06-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07648992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07648992, "Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07648992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*